Comparison of outcome with amnion versus Alginate for skin graft donor site dressing.

Not Applicable

Completed

• Conditions: Skin graft donor site wound; Skin - Other skin conditions; Surgery - Other surgery

• Registration Number: ACTRN12618001632280
• Lead Sponsor: Roeya-E-Rasul

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-10-03
• Study Completion: 2019-11-22
• Last Update Posted: 3 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Candidates of Split-thickness skin graft harvested with Zimmer dermatome with the thickness of 0.010 inches and width of 4 inches, single sheet (20-30 cm), harvested from right or left thigh

Exclusion Criteria

1.Patients with allergy to Alginate or any of the other products used determined on history and examination
2.Immunocompromised patients- with systemic infection determined on clinical examination.
3.Patients with serious and uncontrolled co-morbidities: diabetes, hypertension, ischemic heart disease determined on history and clinical examination.
4.Pregnant and lactating females.
5.Burn patients.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Wound healing by complete epithelization assessed clinically by seeing the complete resurfacing of skin by epithelium.[Patients will be assessed on post-operative day 1, 5, and 10. Finally, the post-operative day on which the dressing spontaneously leaves the donor site, revealing a healed wound, will be noted up to 1 month.]